StayCurrentMD · LncRNA MEG9 Promotes Inflammation and Liver Fibrosis Through S100A9 in Biliary Atresia
Article1 min read·Published Jul 2024Older

LncRNA MEG9 Promotes Inflammation and Liver Fibrosis Through S100A9 in Biliary Atresia

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Jul 2024 · 1 min read

In brief

In brief

This research investigates the molecular mechanisms underlying biliary atresia, focusing on how long noncoding RNA MEG9 contributes to inflammation and liver fibrosis through S100A9 protein interactions. The study advances understanding of BA pathogenesis and may inform future therapeutic targets for this pediatric cholestatic liver disease.

Written by the GCMD Library team from the article.

The pathogenesis of biliary atresia (BA) remains elusive. We aimed to investigate the role of long noncoding RNA (lncRNA) MEG9 in BA.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →